Lavakumar Karyampudi, PhD, Moffitt Cancer Center, Tampa, FL, describes some of the research conducted at the Cell Therapies Core (CTC) at Moffitt Cancer Center. Various cell therapies are under investigation, including tumor-infiltrating lymphocyte (TIL) and autologous chimeric antigen receptor (CAR) T-cell therapies. The center additionally works with companies in early-stage clinical trials and to streamline manufacturing processes, and providing guidance on Chemistry, Manufacturing and Controls (CMC). This interview took place at Advanced Therapies Week 2022.
Lavakumar Karyampud, PhD, is an employee of Moffitt Cancer Center.